InvestorsHub Logo
Followers 61
Posts 6983
Boards Moderated 0
Alias Born 10/03/2004

Re: Foosfund post# 227695

Wednesday, 01/01/2020 11:50:39 AM

Wednesday, January 01, 2020 11:50:39 AM

Post# of 462469
Foosfund-BIR was the first stock newsletter I subscribed to in the mid-1980s. I was working for a major pharmaceutical company with a nice 401K plan but decided to develop a small "Vegas" portfolio with perhaps 1% of my salary. I bought my first BIR rec in 1987-CVM (Cel-Sci) developing an immunotherapeutic agent as a first-line drug for head and neck cancer (pre chem-rad). That drug is now nearing the end of its Phase III trial waiting for 298 events (deaths) to occur before ending.
CVM is the example I refer to when investors complain about AVXL (or other developing biotechs) being too slow for finals. After 33 years the company is excited about seeing a positive end in 2020. I've also said at least 80% should not invest in biotechs as they often look at biotech as just another "widget"-planned this week, produced next week, and sold the week thereafter.
I am retired and my income is my IRA funds but my "play money" consists of 10 "gambling" stocks of which AVXL is one of my top two with much promise IMO.
Yes, I also purchased AVXL recommended by BIR a few years back.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News